ストックスクリーナーアプリを入手
1.04
3.24%
-0.04
Lucid Diagnostics Inc (LUCD) 最新ニュース
Lucid Diagnostics: Positioned For A Medicare-Driven Inflection (NASDAQ:LUCD) - Seeking Alpha
LUCD News | LUCID DIAGNOSTICS INC (NASDAQ:LUCD) - ChartMill
Lucid Diagnostics Inc.(NasdaqCM:LUCD) dropped from Russell Small Cap Comp Value Benchmark - marketscreener.com
Lucid Diagnostics Inc.(NasdaqCM: LUCD) dropped from Russell 3000 Value Benchmark - marketscreener.com
Lucid Diagnostics Inc.(NasdaqCM: LUCD) dropped from Russell 2500 Value Benchmark - marketscreener.com
Lucid Diagnostics Inc.(NasdaqCM: LUCD) dropped from Russell 2000 Value Benchmark - marketscreener.com
Lucid Diagnostics Inc. Actuals & Estimates (NASDAQ:LUCD) - TradingView
LUCD Forecast — Price Target — Prediction for 2027 - TradingView
Lucid Diagnostics Shareholders Approve Stock Authorization Increase - TipRanks
Lucid Diagnostics (LUCD) boosts authorized shares to 400M and re-elects directors - Stock Titan
LUCD: All proposals passed, including director elections and share authorization increase - TradingView
Transcript : Lucid Diagnostics Inc.Shareholder/Analyst Call - marketscreener.com
Lucid Diagnostics Inc (LUCD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Lucid Diagnostics Inc (LUCD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Top Lucid Diagnostics (LUCD) Competitors 2026 - MarketBeat
Lucid Diagnostics Inc (LUCD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Lucid Diagnostics Inc (LUCD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Lucid Diagnostics Inc (LUCD) Institutional Confidence - TradingKey
Lucid Diagnostics Inc (LUCD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Lucid Diagnostics Inc (LUCD) Valuation: PE, PB & Fair Value Analysis - TradingKey
Lucid Diagnostics Inc (LUCD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Lucid Diagnostics Inc (LUCD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
LUCD Q1 2026 Earnings: EPS Misses Estimates by 100.7% as Company Reports No RevenueOne-Time Loss Impact - dars.gov.et
Certain Stock Options of Lucid Diagnostics Inc. are subject to a Lock-Up Agreement Ending on 9-JUN-2026. - marketscreener.com
Lucid Diagnostics misses on revenue, but 2026 growth outlook lights up bull case - MSN
Lucid Diagnostics Misses On Revenue, But 2026 Growth Outlook Lights Up Bull Case - Benzinga
LUCD Maintained by Ascendiant Capital -- Price Target Raised to $9.25 - GuruFocus
Why Lucid Diagnostics Inc. (LUCD) Faced a Price Target Reduction After Q1 Results - Yahoo Finance
Lucid Diagnostics Q1 2026 Earnings: EPS Miss Widens as Company Reports Wider-Than-Expected LossManagement Tone Analysis - dars.gov.et
LUCD Q1 2026 Earnings: Significant EPS Miss Amid Pre-Revenue Stage ChallengesRevenue Warning Signal - The Legal Advocate
LUCD Stock Price, Quote & Chart | LUCID DIAGNOSTICS INC (NASDAQ:LUCD) - ChartMill
LUCDLucid Diagnostics Inc Stock Price and Quote - Finviz
Lucid Diagnostics (LUCD) Surges 7% as Momentum Builds Near Key ResistanceTurnaround Stocks - The Legal Advocate
Lucid Diagnostics Q1 2026 Earnings: Wider-than-Expected Loss as Pre-Revenue Firm Advances Commercial Rollout - The Legal Advocate
Director buys 245K Lucid Diagnostics (NASDAQ: LUCD) shares in market - Stock Titan
Lucid Diagnostics (LUCD) Rallies +1.30% as Bulls Target $1.02 2026-05-19Dividend Growth Stocks - The Legal Advocate
Lucid Diagnostics Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:LUCD) 2026-05-17 - Seeking Alpha
Lucid Diagnostics Inc. (LUCD) reports Q1 loss, misses revenue estimates - MSN
PAVmed Inc (PAVM) Q1 2026 Earnings Call Highlights: Strategic Restructuring and Growth ... By GuruFocus - Investing.com Canada
Upcoming Events - FinancialContent
Maxim Group Maintains Lucid Diagnostics(LUCD.US) With Buy Rating, Cuts Target Price to $2 - Moomoo
BTIG Maintains Lucid Diagnostics(LUCD.US) With Buy Rating, Maintains Target Price $2.5 - Moomoo
PAVmed (PAVM) Q1 2026 Earnings Transcript - AOL.com
PAVmed (PAVM) Q4 2025 Earnings Transcript - The Globe and Mail
PAVmed Reports Q1 2026 Financial Results, Highlights Progress in Veris Health FDA Submission and Lucid Diagnostics Commercial Expansion - Minichart
Earnings Call Summary | Lucid Diagnostics(LUCD.US) Q1 2026 Earnings Conference - 富途牛牛
PAVmed Reports Wider-than-Expected Q1 2026 Loss - AlphaStreet
Earnings call transcript: PAVmed Inc. Q1 2026 shows restructuring gains By Investing.com - Investing.com Australia
Q1 2026 PAVmed Inc Earnings Call Transcript - GuruFocus
Lucid Diagnostics Inc. (NASDAQ:LUCD) Q1 2026 Earnings Call Transcript - Insider Monkey
PAVmed (NASDAQ: PAVM) Q1 2026 results, losses and cash position - Stock Titan
PAVmed Q1: cancer test and implantable monitor push toward coverage, FDA - Stock Titan
Canaccord Genuity Sticks to Its Buy Rating for Lucid Diagnostics (LUCD) - The Globe and Mail
PAVmed Provides Business Update and Reports First Quarter 2026 Financial Results - PR Newswire
Lucid says $44.8M pro forma cash extends runway well into 2027 as it awaits Medicare LCD - MSN
Lucid Diagnostics Inc.Common Stock (NQ: LUCD - FinancialContent
PAVmed Inc.Series Z Warrant (NQ: PAVMZ - FinancialContent
Lucid Diagnostics Earnings Call Balances Progress, Pressure - TipRanks
PAVmed Reports Business Expansion and Financial Update - Intellectia AI
PAVmed (NASDAQ: PAVM) posts Q1 2026 loss and flags going concern risks - Stock Titan
0.18%
0.19%
大文字化:
|
ボリューム (24 時間):